First, several analogues of MTM, such as EC-8042, have been reported to enhance its pharmacological profile while retaining a strong anti-tumour effect in sarcomas and other types of tumours [6, 8, 11, 12, 37, 39]. Here, MT1DP is linked to sarcoma.